Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -45.19%-1.09M | -44.90%-1.83M | 1.10%-3.34M | 19.78%-573.61K | -8.78%-750.35K | 16.86%-749.18K | -18.28%-1.26M | -30.51%-3.38M | 1.61%-715.05K | -27.85%-689.79K |
| Net income from continuing operations | -87.79%-1.51M | -11.91%-1.16M | 67.88%-4.21M | 86.80%-1.37M | -0.04%-998.55K | 11.60%-805.75K | -30.18%-1.03M | -482.81%-13.11M | -2,229.85%-10.41M | -70.14%-998.13K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --10.32M | ---- | ---- |
| Remuneration paid in stock | 29.25%238.2K | 28.42%328.68K | -13.88%677.64K | -6.06%86.1K | -5.03%151.31K | -17.82%184.29K | -17.88%255.94K | 6.41%786.89K | -47.57%91.66K | -28.03%159.33K |
| Deferred tax | ---- | ---- | 184.19%588.56K | ---- | ---- | ---- | ---- | -202.27%-699.08K | ---- | ---- |
| Other non cashItems | 55.43%-60.78K | -26.38%-150.96K | 14.52%-293.15K | -77.15%-26.16K | 79.09%-11.16K | -9.45%-136.37K | 20.48%-119.45K | 9.34%-342.96K | 90.05%-14.77K | -54.67%-53.38K |
| Change In working capital | 2,764.55%247.93K | -132.16%-854.04K | 69.70%-99.33K | 3,856.31%151.83K | -46.61%108.06K | 109.70%8.66K | 15.80%-367.87K | 29.74%-327.78K | 94.63%-4.04K | 244.83%202.39K |
| -Change in receivables | 118.91%2.51K | -58.20%-115.64K | -44.93%16.21K | 1,320.00%23.71K | 59.34%78.86K | -162.15%-13.26K | -69.80%-73.1K | 160.39%29.44K | -86.78%1.67K | 23.61%49.49K |
| -Change in prepaid assets | -94.87%4.63K | -388.49%-653.32K | -184.23%-17.63K | -117.85%-7.87K | -76.22%33.92K | 248.54%90.07K | -1.08%-133.74K | 91.35%-6.2K | 677.90%44.11K | 8,677.27%142.64K |
| -Change in payables and accrued expense | 453.29%240.8K | 47.17%-85.08K | 72.11%-97.91K | 175.02%135.99K | -103.75%-4.72K | 17.98%-68.16K | 24.26%-161.03K | -1.43%-351.02K | -93.81%-181.27K | 170.72%125.97K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---115.71K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -45.19%-1.09M | -44.90%-1.83M | 1.10%-3.34M | 19.78%-573.61K | -8.78%-750.35K | 16.86%-749.18K | -18.28%-1.26M | -30.51%-3.38M | 1.61%-715.05K | -27.85%-689.79K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 69.16%-682.44K | -75.91%-1.58M | 9.57%-3.51M | 111.62%43.26K | -7.89%-447.48K | 11.24%-2.21M | -48.14%-896.23K | -349.00%-3.89M | -16.17%-372.29K | -129.72%-414.75K |
| Net PPE purchase and sale | 69.16%-682.44K | -76.27%-1.58M | 3.66%-3.68M | 67.06%-124.11K | -29.43%-447.48K | 11.24%-2.21M | -48.14%-896.23K | -48.33%-3.82M | -27.25%-376.74K | -1.87%-345.73K |
| Net business purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -95.01%85.44K | 118.24%4.45K | ---- |
| Net other investing changes | --0 | --3.18K | 211.58%167.37K | ---- | ---- | ---- | ---- | ---150K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 69.16%-682.44K | -75.91%-1.58M | 9.57%-3.51M | 111.62%43.26K | -7.89%-447.48K | 11.24%-2.21M | -48.14%-896.23K | -349.00%-3.89M | -16.17%-372.29K | -129.72%-414.75K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 153.18K | -1.11%4.95M | -31.06%5.43M | -82.26%422.76K | 0 | 0 | -8.83%5M | 16,213.06%7.87M | 6,254.69%2.38M | 0 |
| Net issuance payments of debt | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---50K | ---- | ---- |
| Net common stock issuance | --0 | -5.85%5.14M | -30.78%5.89M | -83.09%422.76K | --0 | --0 | -8.99%5.46M | --8.5M | --2.5M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | --0 | 57.49%-195.22K | 20.99%-459.29K | --0 | --0 | --0 | 10.71%-459.29K | ---581.31K | ---66.95K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --153.18K | -1.11%4.95M | -31.06%5.43M | -82.26%422.76K | --0 | --0 | -8.83%5M | 16,213.06%7.87M | 6,254.69%2.38M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -59.03%1.89M | -80.03%355.54K | 52.19%1.78M | -4.52%463.13K | 4.49%1.66M | -7.24%4.62M | 52.19%1.78M | -74.41%1.17M | -77.75%485.07K | 21.06%1.59M |
| Current changes in cash | 45.41%-1.62M | -45.87%1.54M | -333.40%-1.43M | -108.30%-107.59K | -8.45%-1.2M | 12.73%-2.96M | -25.47%2.84M | 117.94%610.63K | 228.32%1.3M | -227.43%-1.1M |
| End cash Position | -83.33%276.89K | -59.03%1.89M | -80.03%355.54K | -80.03%355.54K | -4.52%463.13K | 4.49%1.66M | -7.24%4.62M | 52.19%1.78M | 52.19%1.78M | -77.75%485.07K |
| Free cash from | 40.24%-1.77M | -57.91%-3.41M | 2.46%-7.02M | 36.09%-697.72K | -15.67%-1.2M | 12.73%-2.96M | -29.07%-2.16M | -39.40%-7.2M | -6.74%-1.09M | -17.82%-1.04M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.